哈莱纳醇通过抑制Staphylococcus aureus中的Sortase A来阻止葡萄球菌蛋白A在细胞壁表面的定
Jaepil Lee1, Jae-Hyeong Choi2,3, Jayho Lee1
1Department of Agricultural Biotechnology, College of Agriculture and Life Sciences and Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea.
海洋海绵化合物,如哈莱纳醇,抑制Sortase A (SrtA) 活性,阻断Staphylococcus aureus中的表面蛋白质定. 这一发现提供了潜在的新抗感染策略来对抗细菌毒性.
科学领域:
- 海洋天然产品 化学 化学
- 微生物学 微生物学
- 生物化学 生物化学
背景情况:
- 排序酶A (SrtA) 对于将表面蛋白质固定在细菌细胞壁上至关重要.
- 黄金葡萄球菌的毒性与SrtA介导的蛋白质显示有关.
研究的目的:
- 为了从海洋天然产品中识别Sortase A (SrtA) 抑制剂.
- 为了阐明海洋五环多基基体对SrtA抑制的机制.
主要方法:
- 从海洋海绵Xestospongia sp.中分离和阐明化合物的结构.
- 生物化学测试以确定SrtA抑制活性 (IC50).
- 分子生物学技术包括RT-PCR,西部斑点和免疫光显微镜.
主要成果:
- 分离了六种五环多基化物;哈莱纳醇显示出强烈的SrtA抑制 (IC50 = 13.94μM).
- 类醇不会影响srtA或spa基因转录.
- 哈莱纳醇抑制Sortase A活性,防止表面蛋白A (SpA) 固定在细胞壁上.
结论:
- 烯醇有效地抑制SrtA介导的SPA细胞壁在S. aureus中的定.
- 来自海洋的五环多基基是开发针对S. aureus毒性的抗感染药物的有希望的候选者.
更多相关视频
10:00Targeting Biofilm Associated Staphylococcus aureus Using Resazurin Based Drug-susceptibility Assay
Published on: May 5, 2016
11:59Isolation of Lipoprotein Particles from Chicken Egg Yolk for the Study of Bacterial Pathogen Fatty Acid Incorporation into Membrane Phospholipids
Published on: May 15, 2019
相关概念视频
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
